1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 1: 
Characteristics of the total cohort of VLBW
CharacteristicNo. of Infants (n = 96)
Birth weight1063 ± 292
Gestational age, weeks27.9 ± 2.4
Male/Female48/48
Singletons64
Intrauterine growth restriction25
Prolonged Ruptured Membranes22
Oxygen therapy, days26.8 ± 38
Mean arterial pressure <30 mmHg18*
Inotropic use for low blood pressure34
Patent ductus arteriosus†45
Intraventricular hemorrhage grade III or IV4
Pneumothorax6
  • * Of 66 infants with intra-arterial catheter monitoring.
  • † Confirmed at echocardiography.